Trial Profile
To explore if selegiline reduced 18F-THK5351 signal in AD and dementia patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs Fluorine 18 THK 5351 (Primary) ; Selegiline (Primary) ; Flutafuranol F 18
- Indications Alzheimer's disease; Dementia
- Focus Diagnostic use
- 04 Oct 2018 New trial record